Cargando…
How should extra‐large Lugol‐unstained lesions of the esophagus be treated? Results from a population‐based cohort study
BACKGROUND: Current guidelines recommend only severe dysplasia and above (SDA) lesions of the esophageal squamous epithelium for clinical intervention. However, the histopathologic diagnosis derived from tissue biopsies may be subject to underestimation of severity. METHODS: 1073 participants from w...
Autores principales: | Liu, Mengfei, Qi, Zifan, Zhou, Ren, Guo, Chuanhai, Liu, Anxiang, Yang, Haijun, Li, Fenglei, Duan, Liping, Shen, Lin, Wu, Qi, Liu, Zhen, Pan, Yaqi, Liu, Fangfang, Liu, Ying, Cai, Hong, He, Zhonghu, Ke, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587922/ https://www.ncbi.nlm.nih.gov/pubmed/37732496 http://dx.doi.org/10.1002/cam4.6592 |
Ejemplares similares
-
Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population
por: Liu, Mengfei, et al.
Publicado: (2022) -
Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study
por: Liu, Zhen, et al.
Publicado: (2023) -
Telomerase activity of the Lugol-stained and -unstained squamous epithelia in the process of oesophageal carcinogenesis
por: Inai, M, et al.
Publicado: (2001) -
Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
por: Wang, Minmin, et al.
Publicado: (2021) -
Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus
por: Kaneko, K, et al.
Publicado: (2007)